Literature DB >> 29751879

Hepatic Adenomas: Classification, Controversies, and Consensus.

Michael Torbenson1.   

Abstract

Rapid advances in molecular and anatomic pathology have greatly improved our understanding of hepatocellular adenomas. Principle among them is a clinically relevant, histology-based classification that identifies hepatic adenomas at greatest risk for malignant transformation. This new classification system has led to general consensus on the major subtypes of hepatic adenomas. However, controversy remains regarding how to incorporate less common types of hepatic adenomas into the classification system and how to incorporate adenoma subtyping into clinical care. This article provides an in-depth review of how adenomas are classified, with a focus on the current rationale, the consensus, and controversies.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Androgen adenoma; Beta-catenin activated adenoma; Classification; HNF1 alpha inactivated adenoma; Hepatic adenoma; Heptaocellular adenoma; Histology; Inflammatory adenoma; Malignant transformation; Myxoid adenoma; Pathology; Pigmented adenoma

Mesh:

Substances:

Year:  2018        PMID: 29751879     DOI: 10.1016/j.path.2018.02.007

Source DB:  PubMed          Journal:  Surg Pathol Clin        ISSN: 1875-9157


  9 in total

Review 1.  Normal and Neoplastic Growth Suppression by the Extended Myc Network.

Authors:  Edward V Prochownik; Huabo Wang
Journal:  Cells       Date:  2022-02-21       Impact factor: 6.600

2.  FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors.

Authors:  David Dum; Ana Ocokoljic; Maximilian Lennartz; Claudia Hube-Magg; Viktor Reiswich; Doris Höflmayer; Frank Jacobsen; Christian Bernreuther; Patrick Lebok; Guido Sauter; Andreas M Luebke; Eike Burandt; Andreas H Marx; Ronald Simon; Till S Clauditz; Sarah Minner; Anne Menz; Franziska Büscheck; Natalia Gorbokon; Stefan Steurer; Niclas C Blessin; Till Krech
Journal:  Virchows Arch       Date:  2022-08-11       Impact factor: 4.535

3.  Hepatic Adenomas in Patients 60 and Older Are Enriched for HNF1A Inactivation and Malignant Transformation.

Authors:  Saba Yasir; Zongming E Chen; Dhanpat Jain; Sanjay Kakar; Tsung-Teh Wu; Matthew M Yeh; Michael S Torbenson
Journal:  Am J Surg Pathol       Date:  2022-04-06       Impact factor: 6.298

4.  Hepatocellular adenoma: Where are we now?

Authors:  Xi Wang; Xuchen Zhang
Journal:  World J Gastroenterol       Date:  2022-04-14       Impact factor: 5.374

Review 5.  Hepatocellular adenomas: recent updates.

Authors:  Haeryoung Kim; Young Nyun Park
Journal:  J Pathol Transl Med       Date:  2021-04-07

6.  ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical Practice.

Authors:  Margaux Sala; Delphine Gonzales; Thierry Leste-Lasserre; Nathalie Dugot-Senant; Valérie Paradis; Sylvaine Di Tommaso; Jean-William Dupuy; Vincent Pitard; Cyril Dourthe; Amedeo Sciarra; Christine Sempoux; Linda D Ferrell; Andrew D Clouston; Gregory Miller; Mathew M Yeh; Swan Thung; Annette S H Gouw; Alberto Quaglia; Jing Han; Ji Huan; Cathy Fan; James Crawford; Yasuni Nakanuma; Kenichi Harada; Brigitte le Bail; Claire Castain; Nora Frulio; Hervé Trillaud; Laurent Possenti; Jean-Frédéric Blanc; Laurence Chiche; Christophe Laurent; Charles Balabaud; Paulette Bioulac-Sage; Anne Aurélie Raymond; Frédéric Saltel
Journal:  Hepatol Commun       Date:  2020-04-11

7.  Coordinated Cross-Talk Between the Myc and Mlx Networks in Liver Regeneration and Neoplasia.

Authors:  Huabo Wang; Jie Lu; Frances Alencastro; Alexander Roberts; Julia Fiedor; Patrick Carroll; Robert N Eisenman; Sarangarajan Ranganathan; Michael Torbenson; Andrew W Duncan; Edward V Prochownik
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2022-03-05

8.  Morphologic and Molecular Findings in Myxoid Hepatic Adenomas.

Authors:  Daniel J Rowan; Saba Yasir; Zongming E Chen; Taofic Mounajjed; Sibel Erdogan Damgard; Lisa Cummins; Lizhi Zhang; Emma Whitcomb; Vince Falck; Sanford M Simon; Aatur D Singhi; Michael S Torbenson
Journal:  Am J Surg Pathol       Date:  2021-08-01       Impact factor: 6.298

9.  Regenerative hepatic pseudotumor: a new pseudotumor of the liver.

Authors:  Michael Torbenson; Saba Yasir; Robert Anders; Cynthia D Guy; Hee Eun Lee; Sudhakar K Venkatesh; Tsung-Teh Wu; Zongming Eric Chen
Journal:  Hum Pathol       Date:  2020-03-25       Impact factor: 3.526

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.